Attendees:
501 Ventures, LLC
82VS
ADOCIA
Advent Capital Management, LLC
AFK & Partners Asset Management LLC
age1 Capital Management, LLC
AGED Diagnostics
Ally Bridge Group
Alphala Co., Ltd.
ALSA Ventures
Alveus Therapeutics, Inc.
Amgen, Inc.
Andera Partners SA
Antag Therapeutics
Arkin Capital
Aureka Biotechnologies, Inc.
Balyasny Asset Management L.P.
BioAge Labs, Inc.
BIOSTART Consulting GmbH
Boehringer Ingelheim International GmbH
Breslin AG
Candlewood Management
Canopy Clinical Research
Eccogene Inc.
Eight Bridges
Eli Lilly and Company
Elliott Management Corporation
Eos SENOLYTIX, Inc.
Expert Systems, Inc
F. Hoffmann-La Roche AG
Fenix Group International, LLC
Forty51 Ventures AG
Foundation for the National Institutes of Health (FNIH)
FreeMind Group
Generation Fund Life Sciences Fund I
GL Capital Group
Gordian Biotechnology
HBM Partners AG
Health Innovation Capital
Hevolution
Hummingbird Ventures
iBio, Inc.
Invus SAS
Ipsos Healthcare Advisory Service
Iroko Lifesciences
Kailera Therapeutics
Lifespan Vision Ventures LLC
Lumanity
MitoRx Therapeutics
Nitinotes Surgical
NodThera, Inc.
Novartis
Novo Nordisk A/S
Oppenheimer & Co. Inc.
Perspectum Ltd.
Prevail Partners LLC
PriveBio, Inc.
Privos Capital
Ridgeline Discovery GmbH
RiverVest Partner
Rivus Pharmaceuticals, Inc.
Rona Therapeutics
RoX Health
RTW Investments, LLC
Rubedo Life Sciences
Sachs Testing
SaniMed Science Group
Seventure Partners
Shanda Grab Ventures Limited
Stifel
StoneX Group Inc.
Tailwinds Vc
TransPacific Venture Capital Partners
Tune Therapeutics
V-Bio Ventures BV
Vasa Therapeutics
Versant Ventures
Wave Life Sciences
Zealand Pharma A/S
Last updated: June 8, 2026